ImmunityBio, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $727.1M | $389.6M | $36.4M |
| Jun 2022 | $739.7M | $317.7M | $61.9M |
| Sep 2022 | $782.0M | $352.9M | $104.2M |
| Dec 2022 | $812.2M | $362.4M | $104.6M |
| Mar 2023 | $875.1M | $343.4M | $88.5M |
| Jun 2023 | $936.4M | $291.2M | $43.5M |
| Sep 2023 | $843.1M | $432.4M | $178.0M |
| Dec 2023 | $1.09B | $504.5M | $265.5M |
| Mar 2024 | $1.09B | $400.7M | $133.0M |
| Jun 2024 | $1.14B | $444.3M | $130.1M |
| Sep 2024 | $1.11B | $364.6M | $112.0M |
| Dec 2024 | $871.1M | $382.9M | $143.4M |
| Mar 2025 | $894.2M | $303.8M | $60.7M |
| Jun 2025 | $971.9M | $402.1M | $137.7M |
| Sep 2025 | $1.04B | $519.0M | $60.2M |
| Dec 2025 | $1.00B | $501.9M | $88.3M |
| Mar 2026 | $1.52B | $646.6M | $205.2M |
| Jun 2026 | $1.67B | $628.5M | $75.7M |